Medicare Enrolled
Dr. Alex Lam, MD
Rheumatology · Pembroke Pines, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lam
Dr. Alex Lam is a rheumatology specialist in Pembroke Pines, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lam performed 134,361 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lam received a total of $38,795 from 63 pharmaceutical and/or device companies across 1262 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 17% volume in FL
$38,795 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 94983 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗134,361
Medicare services
Top 17% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
67,200 | $4 | $11 |
| Tocilizumab injection (Actemra) | 35,040 | $5 | $9 |
| Romosozumab injection (Evenity) for osteoporosis | 17,221 | $8 | $13 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
7,601 | $34 | $85 |
| Denosumab injection (Prolia/Xgeva) | 4,802 | $18 | $30 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
591 | $58 | $120 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
290 | $89 | $193 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
288 | $8 | $15 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
288 | $12 | $25 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
288 | $105 | $215 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
288 | $4 | $20 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
177 | $23 | $46 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $60 | $136 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $126 | $254 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
65 | $50 | $125 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
30 | $8 | $20 |
| Injection, methylprednisolone acetate, 40 mg | 17 | $5 | $11 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $84 | $169 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.9% high complexity
93.6% medium
0.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$38,795
Total received (2018-2024)
Avg $5,542/year across 7 years
Top 14% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
1,262
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,675
2023
$2,981
2022
$3,497
2021
$3,697
2020
$10,384
2019
$11,380
2018
$4,180
Payments by company (2024)
Janssen Biotech, Inc.
$517
Amgen Inc.
$346
ABBVIE INC.
$293
UCB, Inc.
$260
AstraZeneca Pharmaceuticals LP
$196
Lilly USA, LLC
$182
Mallinckrodt Hospital Products Inc.
$170
Aurinia Pharma U.S., Inc.
$156
PFIZER INC.
$110
DePuy Synthes Sales Inc.
$100
ANI Pharmaceuticals, Inc.
$75
Radius Health, Inc.
$68
GlaxoSmithKline, LLC.
$63
E.R. Squibb & Sons, L.L.C.
$42
Kiniksa Pharmaceuticals International, plc
$38
SOBI, INC
$38
Kyowa Kirin, Inc.
$21
Top 3 companies account for 43.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$18,299
Janssen Biotech, Inc.
$2,367
UCB, Inc.
$2,352
Novartis Pharmaceuticals Corporation
$1,214
Horizon Therapeutics plc
$1,161
PFIZER INC.
$1,014
Mallinckrodt Hospital Products Inc.
$919
GlaxoSmithKline, LLC.
$829
AstraZeneca Pharmaceuticals LP
$797
ABBVIE INC.
$777
E.R. Squibb & Sons, L.L.C.
$752
Radius Health, Inc.
$747
Lilly USA, LLC
$728
Genentech USA, Inc.
$712
Aurinia Pharma U.S., Inc.
$689
AbbVie, Inc.
$496
AbbVie Inc.
$406
Mallinckrodt LLC
$380
Celgene Corporation
$365
Horizon Pharma plc
$276
Alexion Pharmaceuticals, Inc.
$271
Mallinckrodt Enterprises LLC
$261
Janssen Scientific Affairs, LLC
$242
ANI Pharmaceuticals, Inc.
$230
DePuy Synthes Sales Inc.
$211
Actelion Pharmaceuticals US, Inc.
$185
Octapharma USA, Inc.
$185
GENZYME CORPORATION
$169
Flexion Therapeutics, Inc.
$161
Pacira Therapeutics, Inc.
$146
Hikma Pharmaceuticals USA
$122
SOBI, INC
$89
Organon LLC
$79
TerSera Therapeutics LLC
$69
MEDEXUS PHARMA, INC.
$68
GRT US Holding, Inc.
$66
Sobi, Inc
$65
Takeda Pharmaceuticals U.S.A., Inc.
$60
MEDAC PHARMA, INC.
$58
Teva Pharmaceuticals USA, Inc.
$54
SANOFI-AVENTIS U.S. LLC
$52
Exeltis, USA Inc.
$51
FIDIA PHARMA USA INC.
$51
Ferring Pharmaceuticals Inc.
$50
Mylan Institutional Inc.
$48
Antares Pharma, Inc.
$46
Kyowa Kirin, Inc.
$41
Kiniksa Pharmaceuticals, Ltd.
$39
Boston Scientific Corporation
$38
Kiniksa Pharmaceuticals International, plc
$38
Ironwood Pharmaceuticals, Inc
$38
Fresenius Kabi USA, LLC
$34
Pacira Pharmaceuticals Incorporated
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Alvogen Inc
$21
Pernix Therapeutics Holdings, Inc.
$20
Avanos Medical
$19
West-Ward Pharmaceuticals
$17
Bioventus LLC
$17
Daiichi Sankyo Inc.
$15
Avion Pharmaceuticals
$15
Kowa Pharmaceuticals America, Inc.
$13
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 59.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Arcalyst · BENLYSTA · Balcoltra · Bimzelx · COOLIEF COOLED RADIOFREQUENCY · COSENTYX · Cimzia · Crysvita · DUEXIS · DUZALLO · Durolane · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · HYALGAN · Hulio · Humira · Hymovis · ILARIS · INFLECTRA · INJECTAFER · Iovera · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NEXPLANON · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · ORTHOVISC · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QMIIZ ODT · Qutenza · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · SOVUNA · STELARA · STRENSIQ · Seglentis · Strensiq · TALTZ · TAVNEOS · TEPEZZA · TERIPARATIDE · TREMFYA · Tavneos · Trintellix · Truxima · Tymlos · UPTRAVI · Uloric · VIMOVO · XELJANZ · XYOSTED · ZOHYDRO ER · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
94
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HOSPITAL WEST
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lam is a mixed practice specialist, with above-average Medicare volume (top 17% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lam experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Lam performed 67,200 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lam receive payments from pharmaceutical companies?
Yes. Dr. Lam received a total of $38,795 from 63 companies across 1,262 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lam's costs compare to other rheumatologists in Pembroke Pines?
Dr. Lam's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Pembroke Pines
Browse rheumatologists in Pembroke Pines ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology